The role of medication adherence as a determinant of blood pressure control in a managed care population

Disease Management and Health Outcomes

Volumn 15, Issue 4, 2007, Pages 249-256

  Shah, Nilay D ^a   Steiner, Maryann E ^b   Vermeulen, Lee C ^b   Fleming, Lawrence A ^c   Cory, Patrick R ^b,d  

^a MAYO CLINIC   (United States)

^b University of Wisconsin Health   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d Unity Health Insurance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; COMORBIDITY; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL RECORD; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; QUALITY OF LIFE;

EID: 34548335238     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200715040-00006     Document Type: Article

References (27)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics: 2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007 Feb 6; 115 (5): e69-171
2. He J, Muntner P, Chen J, et al. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002; 162: 1051-8
3. Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289: 2083-93
4. Krousel-Wood M, Thomas S, Muntner P, et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19 (4): 357-62
5. Nuesch R, Schroeder K, Dieterle T, et al. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 2001; 323: 142-6
6. Krall R. Interaction of compliance and patient safety. In: Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, Ltd, 1991: 19-25
7. Christensen D, Williams R, Goldberg H, et al. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997; 35 (11): 1164-70
8. Patel R, Taylor S. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother 2002; 36: 40-5
9. Ren X, Kazis L, Lee A, et al. Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther 2002; 27: 47-56
10. Oliveria S, Lapuerta P, McCarthy B, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162: 413-20
11. Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006; 12 (3): 239-45
12. Morris AB, Li JJ, Kroenke K, et al. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy 2006; 26 (4): 483-92
13. Schroeder K, Fahey T, Hay AD, et al. Relationship between medication adherence and blood pressure in primary care: prospective study. J Hum Hypertens 2006; 20 (8): 625-7
14. Maronde R, Chan L, Larsen F, et al. Underutilization of antihypertensive drugs and associated hospitalization. Med Care 1989; 27 (12): 1159-66
15. Godley P, Pham H, Rohack J, et al. Opportunities for improving the quality of hypertension care in a managed care setting. Am J Health Syst Pharm 2001; 58: 1728-33
16. Steiner J, Prochazka A. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997; 50 (1): 105-16
17. Dezii C. Persistence with drug therapy: a practical approach using administrative claims data. Manag Care 2001 Feb; 10 (2): 42-5
18. Steiner J, Koepsell T, Fihn S, et al. A general method of compliance assessment using centralized pharmacy records. Med Care 1988; 26 (8): 814-23
19. Alexander M, Tekawa I, Hunkeler E, et al. Evaluating hypertension control in a managed care setting. Arch Intern Med 1999; 159: 2673-7
20. Prescription Solutions Costa Mesa CA. High compliance to antihypertensive regimen tied to fewer CVD events, reduced health care consumption. Formula-ry 2001; 36: 306-7
21. Paramore LC, Halpern M, Lapuerta P, et al. Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am J Manag Care 2001; 7 (4): 389-98
22. Wannemacher AJ, Schepers GP, Townsend KA. Antihypertensive medication compliance in a Veterans Affairs Healthcare System. Ann Pharmacother 2002; 36: 986-91
23. Rizzo J, Simons R. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997; 19 (6): 1446-57
24. Chobian A, Bakris G, Black H, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC VII report. JAMA 2003; 289 (19): 2560-72
25. Lopez J, Meier J, Cunningham F, et al. Antihypertensive medication use in the Department of Veterans Affairs. Am J Hypertens 2004; 17 (12): 1095-9
26. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794-811
27. Valenstein M, Copeland L, Blow F, et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002; 40 (8): 630-9